Radical Cystectomy for Muscle-invasive UCB Offers Better Survival
Radical cystectomy is associated with better long-term overall survival than trimodal therapy, new study shows.
Diagnosis & Disease Information
Pre-Cystectomy Chemo Does Not Up Survival in ‘Real World’ Setting
Finding contrasts with results of randomized clinical trials.
Bladder Surgery Complications Predicted by New Model
Nomograms specific to radical cystectomy currently do not exist to aid stratification of a patient’s risks for complications.
Significant Prostate Cancer Found in Advanced Bladder Cancer Patients
In a study, 53.1% of patients had concomitant prostate cancer in radical cystectomy specimens.
Tumor Features Predict Post-Cystectomy Recurrence
Predictors of distant recurrences after robot-assisted radical cystectomy were mainly dictated by pathological tumor characteristics.
New Study Supports Use of Trimodal Therapy for MIBC
Researchers find no difference in 5-year disease-specific survival between multi-disciplinary bladder-sparing approach and radical cystectomy.
Early Recurrence After Laparoscopic Radical Cystectomy Explored
During first 24 months, 8.7% of patients with favorable pathological characteristics had progressed.
Cytoreductive RC Aids Survival of Metastatic Bladder Cancer Patients
Patients who underwent debulking had significantly longer overall survival compared with those who did not (median 15.7 vs 10 months).
Bladder Preservation Therapy for MIBC Predicts Worse Survival
Mortality risk decreases with increasingly stringent BPT compared with radical cystectomy.
Gender Differences Found in Bladder Cancer Treatment, Survival
Cancer-specific survival at 5 years was 76.9% for men and 71.5% for women.
- Loading...
Loading...
Next post in AUA 2016 Bladder/Kidney Cancer
Loading... 
Loading...